Amneal Pharmaceuticals, Inc. (AMRX) earnings date

Nasdaq · Mid cap · EDGAR filings

Email me when this date changes · free account, one click to stop

How this company behaves

Announces its report date Not enough announcements on file yet to say
Reports after the quarter ends 35 days, typically, give or take 12 (last 8 releases)

Last 8 releases

PeriodReleasedTimingDays after period endFiling
Q3 FY2026Tue, Nov 3, 2026before open 34 8-K
Q2 FY2026Thu, Jul 30, 2026before open 30 8-K
Q1 FY2026Thu, May 7, 2026after close 37 8-K
Q4 FY2025Fri, Feb 27, 2026before open 58 8-K
Q3 FY2025Thu, Oct 30, 2025before open 30 8-K
Q2 FY2025Tue, Aug 5, 2025before open 36 8-K
Q1 FY2025Fri, May 2, 2025before open 32 8-K
Q4 FY2024Fri, Feb 28, 2025before open 59 8-K

What they guided beta

Q3 FY2026 "Document Exhibit 99.1 AMNEAL REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS – Q3 2026 Net Revenue of $863 million; GAAP Net Loss of $22 million; Diluted Loss per Share of $(0.06) – – Adjusted EBITDA of $207 million; Adjusted Diluted EPS of $0.26 – – Updating 2026 Full Year Guidance – BRIDGEWATER, NJ, November 3, 2026 - Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”) today announced its results for the third quarter ended September 30, 2026." exhibit
Q3 FY2026 "“Amneal delivered another quarter of strong, broad-based performance, enabling us to increase our 2026 guidance once more." exhibit
Q3 FY2026 "Adjusted EBITDA in the third quarter of 2026 was $207 million, an increase of 30% compared to the third quarter of 2025, reflecting higher revenue, higher gross profit, and lower operating expenses." exhibit
Q3 FY2026 "Please refer to the “Non-GAAP Financial Measures” section and the accompanying GAAP to non-GAAP reconciliation tables for more information. 1 Updating 2026 Full Year Guidance We are increasing full year 2026 guidance for net revenue, adjusted EBITDA, and adjusted diluted EPS." exhibit
Q2 FY2026 "Document Exhibit 99.1 AMNEAL REPORTS SECOND QUARTER 2026 FINANCIAL RESULTS – Q2 2026 Net Revenue of $796 million; GAAP Net Income of $58 million; Diluted Income per Share of $0.18 – – Adjusted EBITDA of $206 million; Adjusted Diluted EPS of $0.30 – – Raising 2026 Full Year Guidance – – Successful Debt Repricing in July Reduces Interest Cost – BRIDGEWATER, NJ, July 30, 2026 - Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”) today announced its results for the second quarter ended June 30, 2026." exhibit
Q2 FY2026 "This robust first-half performance gives us confidence to raise our full-year 2026 guidance for the second time this year." exhibit
Q2 FY2026 "As we look ahead to the remainder of 2026, 2027 and beyond, we remain highly confident in Amneal’s outlook and the breadth and durability of the opportunities across our portfolio,” said Chirag and Chintu Patel, Co-Founders and Co-Chief Executive Officers of Amneal." exhibit
Q2 FY2026 "Net income attributable to Amneal Pharmaceuticals, Inc. was $58 million in the second quarter of 2026 compared to net income of $22 million in the second quarter of 2025, an increase of 157%, as higher revenue and gross profit, lower interest expense, and a lower tax provision more than offset increased SG&A expense." exhibit
Q2 FY2026 "The repricing is expected to close as early as August 3, 2026." exhibit

Get this as JSON

curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/next/AMRX
# how far back the record goes for this company
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/coverage/AMRX

Put this date on your page

A badge that stays current. It links back to this page and needs no key. Embed it unmodified, with its link to this page intact: the badge is too small to carry the notice below, so the page it links to does.

Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.

AMRX earnings date badge

HTML

<a href="https://veritasdata.dev/company/AMRX/"><img src="https://veritasdata.dev/embed/AMRX.svg" alt="AMRX earnings date" width="240" height="56"></a>

Markdown

[![AMRX earnings date](https://veritasdata.dev/embed/AMRX.svg)](https://veritasdata.dev/company/AMRX/)

Script

<script async src="https://veritasdata.dev/embed/AMRX.js"></script>

Get a free key: 100 calls, every company

Sign in with GitHub or Google. The key works on every endpoint and in the MCP server.

curl -H "X-API-Key: vt_live_..." "https://api.veritasdata.dev/v1/next/AMRX"

Dates come only from SEC EDGAR and company announcements. Nothing here is investment advice.